Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*

Latest action: Substituted by A4852 (ACS)

Voted 6/30/2026View source

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

Docket history

6/30/2026Substituted by A4852 (ACS)
6/11/2026Reported from Senate Committee as a Substitute, 2nd Reading
5/11/2026Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee